Key facts
- This page summarizes Christopher A. Toth's Form 3 filing for BAXTER INTERNATIONAL INC (BAX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 05 Jun 2023, 16:02.
Christopher A. Toth - 01 Jun 2023 Form 3 Insider Report for BAXTER INTERNATIONAL INC (BAX)
- Reporting relationship
- EVP, Group Pres, Kidney Care
- Issuer ticker
- BAX
- Reported as of
- 01 Jun 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 05 Jun 2023, 16:02:30 UTC
- Next SEC filing
- 08 Mar 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew Rice, as attorney in-fact for Christopher A. Toth
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Christopher A. Toth filed Form 3 for BAXTER INTERNATIONAL INC (BAX) on 05 Jun 2023.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BAX
holding
Common Stock, $1 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 01 Jun 2023
- Ownership
- Direct
* marks a reported price that did not pass the local price check.